scaht logo
SCAHT logo
EN DE FR
Toxicologie Réglementaire
Recherche SCAHT logo
Direction du SCAHT SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Financement de la recherche
Éducation SCAHT logo
SCAHT AOP_HUB
Publications
News SCAHT logo
Events
Newsletter / Lettre d'information
Agency News Corner
Ressources SCAHT logo
Links and Tools
Actualités sur les politiques mondiales
Équipe
INSCRIPTION À LA NEWSLETTER

En cas de suspicion d'empoisonnement, contactez Tox Info Suisse

Numéro d'urgence 24h tél. 145

(depuis l'étranger : +41 44 251 51 51)

Contact Confidentialité et mentions légales
EN DE FR
Toxicologie Réglementaire
Recherche SCAHT logo
Direction du SCAHT SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Financement de la recherche
Éducation SCAHT logo
SCAHT AOP_HUB
Publications
News SCAHT logo
Events
Newsletter / Lettre d'information
Agency News Corner
Ressources SCAHT logo
Links and Tools
Actualités sur les politiques mondiales
Équipe
INSCRIPTION À LA NEWSLETTER

En cas de suspicion d'empoisonnement, contactez Tox Info Suisse

Numéro d'urgence 24h tél. 145

(depuis l'étranger : +41 44 251 51 51)

Contact Confidentialité et mentions légales

16 Nov 2012

Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient.

15 Nov 2012

Species-specific differences in the inhibition of human and zebrafish 11β-hydroxysteroid dehydrogenase 2 by thiram and organotins

1 Nov 2012

Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA

17 Oct 2012

Comparison of four drug interaction screening programs

12 Oct 2012

Virtual screening as a strategy for the identification of xenobiotics disrupting corticosteroid action.

1 Oct 2012

Transcriptional regulation of CYP2C19 and its role in altered enzyme activity

19 Sep 2012

Hepatic fat loss in advanced nonalcoholic steatohepatitis: Are alterations in serum adiponectin the cause?

21 Aoû 2012

Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers.

20 Aoû 2012

Analgesics in patients with hepatic impairment: pharmacology and clinical implications

1 Aoû 2012

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection

  • «
  • …
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • …
  • »
logo scaht
logo université de genève
logo université de lausanne
logo fhnw
SCAHT newsletter subscriptions
* indicates required
Please select at least one newsletter

Please select all the ways you would like to hear from SCAHT - Swiss Centre for Applied Human Toxicology / University of Basel:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.